Media ReleasesAuscann Group Holdings

View All Auscann Group Holdings News


AusCann Announces Leadership Transition

• Ms Elaine Darby has advised the Board she intends to step down as Managing Director as part of AusCann’s transition to a sales focused pharmaceutical company

• Since listing AusCann has successfully achieved critical milestones in establishing a market leading position in the emerging Australian medicinal cannabis market

• The Board will now commence a comprehensive executive search to recruit a suitable candidate for the Company’s next phase of development and growth

• Ms Darby will continue in her role to ensure an orderly transition process until an appropriate time to hand over leadership responsibilities is agreed with the Board

Thursday, 27 September 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) wishes to advise that Ms Elaine Darby has informed the Board of her intention to step down as Managing Director of the Company.


For further information please download PDF attached:
Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.